Want to see ALHC full AI Analyst Report?
ALHC Stock Chart & Stats
$13.59
-$0.41(-2.08%)
At close: 4:00 PM EDT
$13.59
-$0.41(-2.08%)
Day’s Range― - ―
52-Week Range$6.01 - $25.12
Previous CloseN/A
Volume698.37K
Average Volume (3M)11.77M
Market Cap
$1.75B
Enterprise Value$5.45B
Total Cash (Recent Filing)$701.71M
Total Debt (Recent Filing)$330.50M
Price to Earnings (P/E)42.3
Beta0.52
Next Earnings
Oct 29, 2026EPS Estimate
-0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.20
Shares Outstanding207,435,150
10 Day Avg. Volume9,612,211
30 Day Avg. Volume11,773,115
Financial Highlights & Ratios
PEG Ratio53.67
Price to Book (P/B)21.81
Price to Sales (P/S)0.99
P/FCF Ratio34.56
Enterprise Value/Market Cap3.11
Enterprise Value/Revenue1.19
Enterprise Value/Gross Profit9.49
Enterprise Value/Ebitda62.98
Forecast
1Y Price Target
$11.63Price Target Upside-14.46% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering10
EPS Forecast (FY)0.14
Revenue Forecast (FY)$5.22B
Bulls Say, Bears Say
Bulls Say
Membership And Revenue GrowthRapid membership expansion and higher revenue guidance indicate strong demand for Alignment’s Medicare Advantage offering. Continued enrollment growth can broaden the premium base, improve operating scale, and support greater earnings capacity if medical costs remain controlled as newer cohorts mature.
Improving Profitability And Cash GenerationThe move from historical losses to positive TTM earnings and substantial operating cash flow demonstrates meaningful financial progress. Strong cash conversion provides funding for clinical investment, technology development, and growth while reducing reliance on external capital as the platform expands.
Clinical And AI CapabilitiesAVA’s ability to identify members associated with a large share of upcoming hospital admissions could strengthen proactive care management. Better targeting of clinical resources may improve outcomes and utilization control, reinforcing Alignment’s technology-led model as membership scales.
Bears Say
2027 Star Ratings DowngradeThe lower Star Rating creates a durable reimbursement and profitability risk because quality performance affects Medicare Advantage bonus economics. Although revenue is not expected to change in 2026–2027, lower quality bonus payments are expected to pressure fiscal 2028 results.
Thin Profit MarginsVery thin profitability leaves limited protection against medical-cost inflation, unfavorable utilization, or reimbursement pressure. Even with strong revenue growth, small changes in care costs or operating expenses could materially affect earnings, making sustained margin improvement essential to the model.
Limited Balance-Sheet CushionThe improved debt position strengthens financial flexibility, but modest equity relative to total assets leaves less room for error if profitability weakens. Historical leverage volatility also means the company must preserve recent earnings and cash-flow gains to maintain a durable balance-sheet cushion.
Alignment Healthcare News
ALHC FAQ
What was Alignment Healthcare’s price range in the past 12 months?
Alignment Healthcare lowest stock price was $6.01 and its highest was $25.12 in the past 12 months.
What is Alignment Healthcare’s market cap?
Alignment Healthcare’s market cap is $1.75B.
When is Alignment Healthcare’s upcoming earnings report date?
Alignment Healthcare’s upcoming earnings report date is Oct 29, 2026 which is in 7 days.
How were Alignment Healthcare’s earnings last quarter?
Alignment Healthcare released its earnings results on Jul 30, 2026. The company reported $0.17 earnings per share for the quarter, beating the consensus estimate of $0.129 by $0.041.
Is Alignment Healthcare overvalued?
According to Wall Street analysts Alignment Healthcare’s price is currently Overvalued.
Does Alignment Healthcare pay dividends?
Alignment Healthcare does not currently pay dividends.
What is Alignment Healthcare’s EPS estimate?
Alignment Healthcare’s EPS estimate is -0.04.
How many shares outstanding does Alignment Healthcare have?
Alignment Healthcare has 207,435,150 shares outstanding.
What happened to Alignment Healthcare’s price movement after its last earnings report?
Alignment Healthcare reported an EPS of $0.17 in its last earnings report, beating expectations of $0.129. Following the earnings report the stock price went down -20.204%.
Which hedge fund is a major shareholder of Alignment Healthcare?
Currently, no hedge funds are holding shares in ALHC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Alignment Healthcare Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$11.63 (-14.46% Downside)
$11.63 (-14.46% Downside)
Blogger Sentiment
Neutral
ALHC Sentiment 53%
Sector Average 67%
Sector Average 67%
Hedge Fund Trend
Decreased
By 195.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $6.7M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.0%
Last 30 Days ▲ 6.7%
Last 30 Days ▲ 6.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-51.79%
12-Months-Change
Fundamentals
Return on Equity
20.02%
Trailing 12-Months
Asset Growth
27.88%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Alignment Healthcare
Alignment Healthcare, Inc. is a technology-driven Medicare Advantage provider operating a healthcare platform focused squarely on the consumer. This organization delivers personalized medical services across the United States, primarily for elderly individuals and others requiring specific support, leveraging its suite of Medicare Advantage plans. The company directly owns and operates Medicare Advantage programs in California, North Carolina, and Nevada. Beyond its proprietary offerings, it also orchestrates and furnishes essential healthcare services—including professional, institutional, and supplementary care—for beneficiaries of select plans from unrelated Medicare Advantage Health Maintenance Organizations. Established in 2013, Alignment Healthcare maintains its corporate base in Orange, California.
ALHC Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a strong growth and margin-improvement story: membership and revenue grew ~31%-32% YoY, adjusted EBITDA rose 48% YoY, MBR improved ~40 bps, cash and leverage are healthy, and management raised revenue and profitability guidance while outlining sizable embedded earnings potential and meaningful clinical/AI investments. Offsetting these positives are intentional near-term investments that will increase Q3/Q4 MBR and SG&A (potentially a double-digit million impact), a smaller-than-last-year new-member sweep benefit, a modest prior-year reserve build (~$6M) and regulatory uncertainty. On balance, the company demonstrates operational execution and scalability while accepting some short-term cost headwinds to pursue longer-term growth and portability.View all ALHC earnings summariesALHC Stock 12 Month Forecast
Average Price Target
$11.63
▼(-14.46% Downside)
Technical Analysis
Ownership Overview
16.38% Insiders
37.08% Mutual Funds
0.43% Other Institutional Investors
19.94% Public Companies and
Individual Investors